PPARγ as a therapeutic target in central nervous system diseases

被引：91
作者：
Sundararajan, Sophia
Jiang, Qingguang
Heneka, Michael
Landreth, Gary
机构：
[1] Case Western Reserve Univ, Sch Med, Alzheimers Res Lab, Dept Neurol, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA
[3] Univ Munster, Dept Neurol, D-14849 Munster, Germany
来源：
NEUROCHEMISTRY INTERNATIONAL | 2006年 / 49卷 / 02期
关键词：
Alzheimer's disease; stroke; multiple sclerosis; Parkinson's disease; amytrophic lateral sclerosis;
D O I：
10.1016/j.neuint.2006.03.020
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Diseases of the central nervous system present a challenge for the development of new therapeutic agents. Nuclear receptors are ligand-activated transcription factors that have proven to be valuable targets for development of new drugs owing to their ability to directly regulate gene expression. The nuclear receptor, peroxisome proliferator-activated receptor gamma (PPAR gamma), has been investigated for its action in ameliorating the development and progression of a number of CNS diseases. PPAR gamma agonists exhibit potent anti-inflammatory effects and appear to have direct neuroprotective actions. PPAR gamma agonists have been shown to be efficacious in animal models of Alzheimer's disease, stroke, multiple sclerosis, Parkinson's disease and amyotrophic lateral sclerosis. The availability of FDA-approved agonists of this receptor will facilitate the rapid translation of these findings into clinical trials for a number of CNS diseases. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码：136 / 144
页数：9
相关论文
共 85 条
[1]   Role of PPAR-γ ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells [J].
Aoun, P ;
Simpkins, JW ;
Agarwal, N .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (07) :2999-3004
[2]   Nuclear hormone receptors and gene expression [J].
Aranda, A ;
Pascual, A .
PHYSIOLOGICAL REVIEWS, 2001, 81 (03) :1269-1304
[3]   TIME-RELATED CHANGES IN MYELOPEROXIDASE ACTIVITY AND LEUKOTRIENE B-4 RECEPTOR-BINDING REFLECT LEUKOCYTE INFLUX IN CEREBRAL FOCAL STROKE [J].
BARONE, FC ;
HILLEGASS, LM ;
TZIMAS, MN ;
SCHMIDT, DB ;
FOLEY, JJ ;
WHITE, RF ;
PRICE, WJ ;
FEUERSTEIN, GZ ;
CLARK, RK ;
GRISWOLD, DE ;
SARAU, HM .
MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1995, 24 (01) :13-30
[4]   Inflammatory mediators and stroke: New opportunities for novel therapeutics [J].
Barone, FC ;
Feuerstein, GZ .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1999, 19 (08) :819-834
[5]   Inflammation and acute stroke [J].
Becker, KJ .
CURRENT OPINION IN NEUROLOGY, 1998, 11 (01) :45-49
[6]   The mechanisms of action of PPARs [J].
Berger, J ;
Moller, DE .
ANNUAL REVIEW OF MEDICINE, 2002, 53 :409-435
[7]   Protective action of the peroxisome proliferator-activated receptor-γ agonist pioglitazone in a mouse model of Parkinson's disease [J].
Breidert, T ;
Callebert, J ;
Heneka, MT ;
Landreth, G ;
Launay, JM ;
Hirsch, EC .
JOURNAL OF NEUROCHEMISTRY, 2002, 82 (03) :615-624
[8]   Peroxisome proliferator-activated receptor-γ-deficient heterozygous mice develop an exacerbated neural antigen-induced Th1 response and experimental allergic encephalomyelitis [J].
Bright, JJ ;
Natarajan, C ;
Muthian, G ;
Barak, Y ;
Evans, RM .
JOURNAL OF IMMUNOLOGY, 2003, 171 (11) :5743-5750
[9]   Peroxisome proliferator-activated receptor γ induces a clearance mechanism for the amyloid-β peptide [J].
Camacho, IE ;
Serneels, L ;
Spittaels, K ;
Merchiers, P ;
Dominguez, D ;
De Strooper, B .
JOURNAL OF NEUROSCIENCE, 2004, 24 (48) :10908-10917
[10]   Inhibition of IκB kinase and IκB phosphorylation by 15-deoxy-Δ12,14-prostaglandin J2 in activated murine macrophages [J].
Castrillo, A ;
Díaz-Guerra, MJM ;
Hortelano, S ;
Martín-Sanz, P ;
Boscá, L .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (05) :1692-1698
123456789